Because there is a correlation between the expression levels of HOX proteins and the sensitivity to BCL2 inhibitor in AML patient samples, the aberrant expression of HOXA9 is the potential mechanism for BCL2-dependence of MLL leukemia (Brumatti et al., 2013; Kontro et al., 2017). This evidence concerns the gene BCL2 and acute myeloid leukemia.